
Ultragenyx Pharmaceutical RARE
$ 15.48
-0.45%
Ultragenyx Pharmaceutical PEG Ratio | RARE
Annual PEG Ratio Ultragenyx Pharmaceutical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.947 | 15 | -1.08 | -0.457 | 13.3 | -4.87 | -0.167 | -0.278 | 0.527 | 0.192 | 0.187 | -0.329 | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 15 | -4.87 | 1.75 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Cytokinetics, Incorporated
CYTK
|
-0.000001 | $ 53.74 | -3.26 % | $ 6.45 M | ||
|
Фармсинтез
LIFE
|
0.297 | - | - | - | ||
|
Prothena Corporation plc
PRTA
|
0.0136 | $ 7.93 | 0.51 % | $ 427 M | ||
|
Codiak BioSciences
CDAK
|
0.0282 | - | -55.98 % | $ 2.15 M | ||
|
DBV Technologies S.A.
DBVT
|
1.56 | $ 10.54 | 7.55 % | $ 1.47 B | ||
|
Rocket Pharmaceuticals
RCKT
|
0.649 | $ 2.38 | -2.05 % | $ 264 M | ||
|
Regeneron Pharmaceuticals
REGN
|
1.08 | $ 904.69 | 0.2 % | $ 94.6 B | ||
|
Replimune Group
REPL
|
-0.204 | $ 21.67 | 8.24 % | $ 2.01 B | ||
|
DiaMedica Therapeutics
DMAC
|
-14 | $ 9.47 | 4.76 % | $ 445 M | ||
|
Royalty Pharma plc
RPRX
|
0.434 | $ 67.31 | -0.39 % | $ 28.9 B | ||
|
Checkpoint Therapeutics
CKPT
|
-0.00928 | - | - | $ 169 M | ||
|
Rhythm Pharmaceuticals
RYTM
|
-19.1 K | $ 111.51 | 6.18 % | $ 7.25 B | ||
|
Puma Biotechnology
PBYI
|
6.48 | $ 8.28 | -15.25 % | $ 414 M | ||
|
SIGA Technologies
SIGA
|
-4.14 | $ 3.12 | 4.55 % | $ 223 M | ||
|
Sage Therapeutics
SAGE
|
0.0153 | - | - | $ 527 M | ||
|
Taro Pharmaceutical Industries Ltd.
TARO
|
-0.277 | - | - | $ 1.62 B | ||
|
Sol-Gel Technologies Ltd.
SLGL
|
-0.218 | $ 61.62 | -2.21 % | $ 172 M | ||
|
SELLAS Life Sciences Group
SLS
|
-0.00162 | $ 8.41 | 6.73 % | $ 917 M | ||
|
Summit Therapeutics
SMMT
|
0.911 | $ 16.34 | 15.15 % | $ 12.2 B | ||
|
Cabaletta Bio
CABA
|
-0.01 | $ 1.3 | 1.17 % | $ 131 M | ||
|
Syndax Pharmaceuticals
SNDX
|
0.084 | $ 9.53 | 1.39 % | $ 826 M | ||
|
Sanofi
SNY
|
15.5 | $ 47.06 | 0.32 % | $ 57.4 B | ||
|
Forma Therapeutics Holdings
FMTX
|
0.233 | - | - | $ 958 M | ||
|
Blueprint Medicines Corporation
BPMC
|
-120 | - | - | $ 8.14 B | ||
|
Horizon Therapeutics Public Limited Company
HZNP
|
-0.759 | - | - | $ 26.6 B | ||
|
Sarepta Therapeutics
SRPT
|
0.0184 | $ 17.8 | 0.68 % | $ 1.78 B | ||
|
Paratek Pharmaceuticals
PRTK
|
-0.0845 | - | - | $ 121 M | ||
|
China SXT Pharmaceuticals
SXTC
|
-0.000148 | $ 2.84 | -3.07 % | $ 1.93 M | ||
|
Takeda Pharmaceutical Company Limited
TAK
|
0.0268 | $ 21.02 | -0.92 % | $ 33.2 B | ||
|
Tarsus Pharmaceuticals
TARS
|
-0.851 | $ 68.11 | 0.87 % | $ 2.85 B | ||
|
ASLAN Pharmaceuticals Limited
ASLN
|
-0.0728 | - | -14.27 % | $ 1.7 M | ||
|
Bio-Techne Corporation
TECH
|
9.26 | $ 72.78 | 0.17 % | $ 11.4 B | ||
|
Teva Pharmaceutical Industries Limited
TEVA
|
-0.369 | $ 42.32 | 1.33 % | $ 48.5 B | ||
|
RedHill Biopharma Ltd.
RDHL
|
0.312 | $ 0.43 | 0.45 % | $ 5.3 B | ||
|
Adverum Biotechnologies
ADVM
|
-0.00407 | - | - | $ 86.2 M | ||
|
Unity Biotechnology
UBX
|
-0.00894 | - | -33.41 % | $ 3.37 M | ||
|
iTeos Therapeutics
ITOS
|
-0.295 | - | - | $ 411 M | ||
|
Shattuck Labs
STTK
|
-0.835 | $ 4.59 | 2.78 % | $ 319 M | ||
|
Seelos Therapeutics
SEEL
|
-0.000255 | - | -47.76 % | $ 6.27 M | ||
|
Evogene Ltd.
EVGN
|
-0.00649 | $ 0.28 | -16.14 % | $ 2.2 M | ||
|
Advaxis
ADXS
|
-0.00008 | - | -9.65 % | $ 45.9 M | ||
|
Protara Therapeutics
TARA
|
0.264 | $ 2.33 | 9.15 % | $ 99.8 M | ||
|
Trevi Therapeutics
TRVI
|
1.94 | $ 14.33 | 11.87 % | $ 1.93 B | ||
|
Galmed Pharmaceuticals Ltd.
GLMD
|
-0.00342 | $ 4.63 | 21.05 % | $ 20 M | ||
|
Fennec Pharmaceuticals
FENC
|
0.000178 | $ 9.79 | 4.26 % | $ 280 M | ||
|
Kiromic BioPharma
KRBP
|
-0.00492 | - | 6.61 % | $ 3.08 M | ||
|
CNS Pharmaceuticals
CNSP
|
-0.000003 | $ 3.92 | -2.24 % | $ 1.74 M | ||
|
Calithera Biosciences
CALA
|
-0.00162 | - | -10.95 % | $ 876 K | ||
|
United Therapeutics Corporation
UTHR
|
0.805 | $ 562.14 | -0.63 % | $ 24.9 B | ||
|
Vericel Corporation
VCEL
|
-0.889 | $ 54.56 | 5.36 % | $ 2.75 B |